Examining how bruxism affects treatment outcomes for periodontitis
Impact of Bruxism in the Outcome of Subgingival Instrumentation for the Management of Stage 2 and Stage 3 Periodontitis: A Comparative Interventional Study.
This study is testing how teeth grinding affects the success of gum disease treatment in healthy adults aged 30-50 with periodontitis.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 58 (estimated) |
| Ages | 30 Years to 50 Years |
| Sex | All |
| Sponsor | Postgraduate Institute of Dental Sciences Rohtak Academic / other |
| Locations | 1 site (Rohtak, Haryana) |
| Trial ID | NCT05995431 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of bruxism on the effectiveness of subgingival instrumentation in patients with Stage 2 and Stage 3 periodontitis. It aims to assess the association between bruxism and periodontal disease by comparing treatment outcomes in patients with and without bruxism. The study will recruit systemically healthy individuals aged 30-50 years who have been diagnosed with periodontitis and will involve interventions such as scaling and root planing. Data will be collected over a 12-14 month period, focusing on clinical attachment levels as a primary outcome measure.
Who should consider this trial
Good fit: Ideal candidates are systemically healthy individuals aged 30-50 years with Stage 2 or Stage 3 periodontitis and bruxism.
Not a fit: Patients with systemic diseases or those taking medications that affect periodontal status may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for patients with periodontitis who also suffer from bruxism.
How similar studies have performed: While the relationship between bruxism and periodontal disease has been explored, this specific interventional approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: TEST GROUP * Systemically healthy patients * Patient having stage 2 or stage 3 periodontitis with bruxism Age between 30-50 years * Minimum 20 teeth present in oral cavity CONTROL GROUP * Systemically healthy patients * Patient having stage 2 or stage 3 periodontitis without bruxism * Age between 30-50 years * Minimum 20 teeth present in oral cavity Exclusion Criteria: * History of systemic disease such as diabetes or autoimmune disease * History of drugs having the potential impact on periodontal status like phenytoin, cyclosporin, calcium-channel blockers or antidepressant drugs * Pregnant or lactating females
Where this trial is running
Rohtak, Haryana
- Post Graduate Institute of Dental Sciences — Rohtak, Haryana, India (Recruiting)
Study contacts
- Principal investigator: Priyanka Chandela, BDS — Pt Bd Sharma Uhsr, Haryana
- Study coordinator: Rajinder Kr Sharma, Mds
- Email: rksharmamds@yahoo.in
- Phone: 9416358222
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.